AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Smiling woman sits on couch while typing on laptop

Medicare telehealth coverage renewed for two years

| 5 Min Read
Hand stacking blocks with health care icons

3.1% bonus revived for physicians participating in Medicare APMs

| 5 Min Read
Smiling caregiver embraces older smiling patient

Lawmakers extend CMS hospital-at-home waiver for five years

| 4 Min Read
Hand holds smartphone

AMA expert says what to do—and not do—when measuring doctor burnout

| 12 Min Read